Cargando…
Immunotherapy against experimental canine visceral leishmaniasis with the saponin enriched-Leishmune(®) vaccine
In order to assess the immunotherapeutic potential on canine visceral leishmaniasis of the Leishmune(®) vaccine, formulated with an increased adjuvant concentration (1 mg of saponin rather than 0.5 mg), 24 mongrel dogs were infected with Leishmania (L.) chagasi. The enriched-Leishmune(®) vaccine was...
Autores principales: | Santos, F.N., Borja-Cabrera, G.P., Miyashiro, L.M., Grechi, J., Reis, A.B., Moreira, M.A.B., Martins Filho, O.A., Luvizotto, M.C.R., Menz, I., Pessôa, L.M., Gonçalves, P.R., Palatnik, M., Palatnik-de-Sousa, C.B. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier Ltd.
2007
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7115527/ https://www.ncbi.nlm.nih.gov/pubmed/17630055 http://dx.doi.org/10.1016/j.vaccine.2007.06.005 |
Ejemplares similares
-
Immunogenicity assay of the Leishmune(®) vaccine against canine visceral leishmaniasis in Brazil
por: Borja-Cabrera, G.P., et al.
Publicado: (2008) -
Nucleoside hydrolase DNA vaccine against canine visceral leishmaniasis
por: Borja-Cabrera, GP, et al.
Publicado: (2009) -
Vaccines for Canine Leishmaniasis
por: Palatnik-de-Sousa, Clarisa B.
Publicado: (2012) -
One Health: The global challenge of epidemic and endemic leishmaniasis
por: Palatnik-de-Sousa, Clarisa B, et al.
Publicado: (2011) -
Phase I and II Clinical Trial Comparing the LBSap, Leishmune(®), and Leish-Tec(®) Vaccines against Canine Visceral Leishmaniasis
por: Aguiar-Soares, Rodrigo Dian de Oliveira, et al.
Publicado: (2020)